Ryan N O'Keefe (Ryan O'Keefe)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Regulatory T Cells

Tyrosine Kinase

Radiofrequency Ablation

Top Venues

Science signaling

Science advances

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Shoukat Afshar-Sterle, Annalisa L E Carli, Ryan N O'Keefe, Janson Tse, Stefanie Fischer, Alexander I Azimpour, David Baloyan, Lena Elias, Pathum Thilakasiri, Onisha Patel, Fleur M Ferguson, Moritz F Eissmann, Ashwini L Chand, Nathanael S Gray, Rita A Busuttil, Alex Boussioutas, Isabelle S Lucet, Matthias Ernst, Michael Buchert
DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression. Science signaling 17 (854) (2024)
Janson Tse, Ryan N O'Keefe, Angela Rigopolous, Annalisa L E Carli, Jo Waaler, Stefan Krauss, Matthias Ernst, Michael Buchert
A Mouse Model for the Rapid and Binomial Assessment of Putative WNT/β-Catenin Signalling Inhibitors. Biomedicines 11 (10) (2023)
Pathum Thilakasiri, Ryan N O'Keefe, Sarah Q To, David Chisanga, Moritz F Eissmann, Annalisa LE Carli, Belinda Duscio, David Baloyan, Rhynelle S Dmello, David Williams, John M Mariadason, Ashleigh R Poh, Bhupinder Pal, Benjamin T Kile, Joseph H A Vissers, Kieran F Harvey, Michael Buchert, Wei Shi, Matthias Ernst, Ashwini L Chand
Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3. Life science alliance 7 (2) (2023)
Ryan N O'Keefe, Annalisa L E Carli, David Baloyan, David Chisanga, Wei Shi, Shoukat Afshar-Sterle, Moritz F Eissmann, Ashleigh R Poh, Bhupinder Pal, Cyril Seillet, Richard M Locksley, Matthias Ernst, Michael Buchert
A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development. Nature communications 14 (1) (2023)
Ashleigh R Poh, Christopher G Love, David Chisanga, James H Steer, David Baloyan, Michaël Chopin, Stephen L Nutt, Jai Rautela, Nicholas D Huntington, Nima Etemadi, Megan O'Brien, Ryan N O'Keefe, Lesley G Ellies, Christophe Macri, Justine D Mintern, Lachlan W Whitehead, Gangadhara Gangadhara, Louis Boon, Ashwini L Chand, Clifford A Lowell, Wei Shi, Fiona J Pixley, Matthias Ernst
Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy. Science advances 8 (25) (2022)